Clinical Trial Update: Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab [Phase 2]

View source ↗

Summary

A Phase II study evaluating primary chemotherapy with paclitaxel, gemcitabine, and trastuzumab in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• Paclitaxel (Taxol) (paclitaxel)
• Trastuzumab (Herceptin) (trastuzumab)

Snippet

Sponsor: Jungsil Ro | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED